Table 1 Baseline characteristics stratified by NAR levels at admission.
Characteristics | All | NAR quartile | P value | |||
|---|---|---|---|---|---|---|
n = 3173 | < 0.15 (n = 794) | 0.15–0.20 (n = 793) | 0.20–0.28 (n = 793) | > 0.28 (n = 793) | ||
Demographics | ||||||
Age, y, mean (SD) | 55.14 (11.99) | 54.49 (12.51) | 55.81 (11.44) | 55.39 (11.89) | 54.85 (12.06) | 0.13 |
Male, n (%) | 1113 (35.1) | 230 (29.0) | 279 (35.2) | 295 (37.2) | 309 (39.0) | < 0.001 |
Smoking, n (%) | Â | Â | Â | Â | Â | Â |
Current | 142 (4.5) | 44 (5.5) | 39 (4.9) | 31 (3.9) | 28 (3.5) | 0.03 |
Ever | 642 (20.2) | 131 (16.5) | 161 (20.3) | 168 (21.2) | 182 (23.0) | Â |
Never | 2389 (75.3) | 619 (78.0) | 593 (74.8) | 594 (74.9) | 583 (73.5) | Â |
Alcohol abuse, n (%) | 630 (19.9) | 125 (15.7) | 164 (20.7) | 173 (21.8) | 168 (21.2) | 0.009 |
SBP, mmHg, mean (SD) | 144.38 (25.12) | 137.07 (21.24) | 144.86 (23.15) | 147.32 (25.35) | 148.29 (28.64) | < 0.001 |
Medical history, n (%) | ||||||
Hypertension | 773 (24.4) | 175 (22.0) | 189 (23.8) | 188 (23.7) | 221 (27.9) | 0.05 |
Diabetes | 188 (5.9) | 50 (6.3) | 39 (4.9) | 46 (5.8) | 53 (6.7) | 0.48 |
CHD | 79 (2.5) | 19 (2.4) | 16 (2.0) | 21 (2.6) | 23 (2.9) | 0.71 |
CRF | 20 (0.6) | 4 (0.5) | 5 (0.6) | 4 (0.5) | 7 (0.9) | 0.80 |
COPD | 229 (7.2) | 50 (6.3) | 70 (8.8) | 54 (6.8) | 55 (6.9) | 0.23 |
Aneurysm characteristics | ||||||
Posterior location, n (%) | 601 (18.9) | 149 (18.8) | 153 (19.3) | 155 (19.5) | 144 (18.2) | 0.90 |
Size, cm, median (IQR) | 0.60 (0.40, 0.80) | 0.60 (0.40, 0.90) | 0.60 (0.40, 0.80) | 0.60 (0.40, 0.80) | 0.60 (0.40, 0.80) | 0.30 |
Hemorrhagic characteristics, n (%) | ||||||
Fisher grade III-IV | 1689 (53.2) | 15 (1.9) | 44 (5.5) | 85 (10.7) | 265 (33.4) | < 0.001 |
Hunt & Hess grade IV-V | 409 (12.9) | 197 (24.8) | 417 (52.6) | 478 (60.3) | 597 (75.3) | < 0.001 |
EVD | 71 (2.2) | 1 (0.1) | 12 (1.5) | 15 (1.9) | 43 (5.4) | < 0.001 |
Treatment of aneurysms, n (%) | ||||||
Clip | 2123 (66.9) | 505 (63.6) | 540 (68.1) | 573 (72.3) | 505 (63.7) | < 0.001 |
Coil | 395 (12.4) | 131 (16.5) | 106 (13.4) | 77 (9.7) | 81 (10.2) | Â |
No treatment | 655 (20.6) | 158 (19.9) | 147 (18.5) | 143 (18.0) | 207 (26.1) | Â |
Biology, median (IQR) | ||||||
Glucose, mmol/L | 6.41 (5.46, 7.77) | 5.43 (4.86, 6.41) | 6.25 (5.50, 7.19) | 6.69 (5.81, 7.95) | 7.48 (6.29, 9.33) | < 0.001 |
Neutrophil, 109/L | 8.07 (5.68, 11.15) | 4.24 (3.16, 5.07) | 7.00 (6.34, 7.78) | 9.52 (8.58, 10.62) | 13.99 (12.16, 16.42) | < 0.001 |
Platelet, 109/L | 165.00 (126.00, 211.00) | 163.00 (123.00, 212.00) | 157.00 (124.00, 204.00) | 169.00 (127.00, 208.00) | 169.00 (129.00, 221.00) | 0.01 |
Lymphocyte, 109/L | 1.10 (0.78, 1.49) | 1.38 (1.02, 1.75) | 1.10 (0.82, 1.46) | 1.02 (0.68, 1.38) | 0.92 (0.67, 1.28) | < 0.001 |
Albumin, g/L | 40.50 (37.10, 43.40) | 40.60 (38.10, 43.10) | 40.70 (37.50, 43.40) | 40.80 (37.30, 43.60) | 39.70 (34.50, 43.80) | < 0.001 |
Monocyte, 109/L | 0.48 (0.34, 0.67) | 0.37 (0.28, 0.47) | 0.46 (0.35, 0.60) | 0.54 (0.38, 0.70) | 0.66 (0.48, 0.91) | < 0.001 |
NAR | 0.20 (0.15, 0.28) | 0.11 (0.08, 0.13) | 0.17 (0.16, 0.19) | 0.24 (0.22, 0.26) | 0.35 (0.31, 0.41) | < 0.001 |
PAR | 4.11 (3.14, 5.32) | 4.06 (3.03, 5.31) | 3.96 (3.07, 5.02) | 4.12 (3.22, 5.29) | 4.40 (3.30, 5.70) | < 0.001 |
NLR | 7.54 (4.24, 12.87) | 2.85 (1.98, 4.32) | 6.29 (4.64, 8.93) | 9.41 (6.62, 13.89) | 15.17 (10.52, 22.44) | < 0.001 |
PLR | 148.26 (105.83, 215.48) | 118.05 (90.72, 167.31) | 141.49 (104.52, 203.57) | 164.75 (118.10, 231.43) | 178.69 (121.54, 263.54) | < 0.001 |
MLR | 0.44 (0.29, 0.66) | 0.26 (0.20, 0.37) | 0.41 (0.30, 0.54) | 0.50 (0.35, 0.71) | 0.69 (0.47, 1.00) | < 0.001 |
SII | 1.19 (0.67, 2.10) | 0.48 (0.33, 0.73) | 0.99 (0.71, 1.44) | 1.57 (1.09, 2.24) | 2.52 (1.62, 4.03) | < 0.001 |